Company profile: Armune Bioscience
1.1 - Company Overview
Company description
- Provider of molecular diagnostic and prognostic tests for prostate, lung and breast cancers, enabling physicians and patients to make more personalized treatment decisions.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Armune Bioscience
Bellwether Bio
HQ: United States
Website
- Description: Provider of novel cell-free DNA-based diagnostic technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bellwether Bio company profile →
iOmx Therapeutics
HQ: Germany
Website
- Description: Provider of first-in-class cancer immunotherapies and discovery platforms targeting novel immune checkpoint modulators on tumor cells. Offerings include iOTargTM, a high-throughput genetic screening platform to identify checkpoint molecules; OMX-0407, an oral spectrum-selective SIK inhibitor in first-in-human trials; and IOMX-0675, a dual LILRB1/LILRB2 antibody to re-activate innate and adaptive immunity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iOmx Therapeutics company profile →
Acetylon
HQ: United States
Website
- Description: Provider of small molecule drugs aimed at realizing the therapeutic potential of histone deacetylase; incorporated in 2008 and based in Boston, Massachusetts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acetylon company profile →
OncoVista Innovative Therapies
HQ: United States
Website
- Description: Provider of anticancer therapy development utilizing tumor-associated biomarkers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OncoVista Innovative Therapies company profile →
Viracta Therapeutics
HQ: United States
Website
- Description: Provider of precision oncology therapies targeting virus-associated malignancies, including Nana-val (nanatinostat + valganciclovir) for relapsed/refractory EBV+ lymphoma (late-stage clinical) and recurrent/metastatic EBV+ solid tumors (early-stage clinical), alongside preclinical products for undisclosed indications and an expanded access policy for investigational treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viracta Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Armune Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Armune Bioscience
2.2 - Growth funds investing in similar companies to Armune Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Armune Bioscience
4.2 - Public trading comparable groups for Armune Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →